Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Lo strumento "Let's Talk Tech" per supportare il processo decisionale sull'uso della tecnologia

21 settembre 2026 aggiornato da: Clara Berridge, University of Washington

Studio meccanicistico sull'intervento comportamentale diadico "Talking Tech" per supportare il processo decisionale sull'uso della tecnologia

The goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties. "Let's Talk Tech" is a new tool to educate people about technologies commonly used to support care and monitor safety, and help families talk about their feelings about them to understand each other's perspectives. The goal of this clinical trial is to learn if "Let's Talk Tech" helps people feel more prepared to make decisions about technologies.

Researchers will compare Let's Talk Tech to usual care (no intervention) to see if Let's Talk Tech increases peoples' preparedness and confidence to make decisions about technologies.

All participants will:

  • Use the Let's Talk Tech web application together with their study partner that takes up to an hour or do nothing.
  • Complete two surveys. The second survey will be taken within 2 weeks of the first.

One participant in each pair will also take a 3rd short survey 3 months after the first.

Panoramica dello studio

Descrizione dettagliata

The goal of this research is to help families understand digital health technology options to support dementia care at home so they can negotiate immediate decisions and future use in an informed way. This is a mechanism-focused trial of Let's Talk Tech (LTT), a single-use, self-administered intervention in the form of a web application. It targets education and interpersonal communication processes to enable informed decision making and planning for technology use that relieves care partners of the burden of making decisions without awareness of the person's preferences. Participants are people living with mild Alzheimer's disease (AD) and AD-related dementias (PLWD) or mild cognitive impairment (MCI) and a care partner. The 120 enrolled dyads (60 per study group) will be randomly assigned to receive either the intervention or usual care control. The intervention is self-administered. All participants will complete measures at baseline and at post-test (2 weeks), and care partners will also complete them 3 months later. Aim 1 will test if LTT compared with usual care improves the hypothesized mechanisms of change that are care partners' technology awareness, understanding, communication satisfaction, and intention to honor the PLWD/MCI's preferences, as well as both care partner- and PLWD/MCI-reported dyadic alignment. Aim 2 will examine if and how those hypothesized mechanisms of change improve the post-test and 3-month primary outcomes of care partner preparedness, decisional conflict, and decision making confidence, and secondary outcomes of PLWD/MCI and care partner sharing of technology preferences beyond the dyad and their confidence that PLWD/MCI's preferences will be honored. Exploratory Aim 3 will examine how, with whom, and for what purpose dyad members share technology preferences and explore factors that vary for those who shared with providers vs. family/friends, with the hope of learning how to expand the reach of this intervention to activate dyads' entire care networks.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

222

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Washington
      • Seattle, Washington, Stati Uniti, 98105
        • University of Washington

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria for Patients:

  • have mild cognitive impairment (MCI) or mild dementia
  • age 55 or older
  • able to understand and speak English

Inclusion Criteria for Co-participants:

  • be identified by the patient as their primary support person
  • age 18 or older
  • able to understand and speak English
  • able to complete LTT together with their study partner at the same time

Exclusion Criteria:

  • None

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Let's Talk Tech intervention

The intervention group will complete the single use self-administered Let's Talk Tech intervention together as a dyad.

Let's Talk Tech is a self-administered dyadic education and communication tool delivered as a web application to support shared decision making about technology use.

Nessun intervento: Usual care

This control group will receive usual care, which means they will complete no intervention.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Preparedness to make technology decisions
Lasso di tempo: baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. Participant rates on a 5-point Likert scale [1="Strongly agree" to 5="Strongly disagree"] how much they agree with the statement that they feel prepared to make decisions about technology use for their study partner.

baseline, 2-week post-test and 3 months
Decisional Conflict Scale
Lasso di tempo: baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. The Decisional Conflict Scale is a 16-item scale with 5 response categories [0= "Strongly agree" to 4="Strongly disagree"]. Higher scores reflect higher decisional conflict in decision making.

baseline, 2-week post-test and 3 months
Decision Making Confidence Scale (adapted)
Lasso di tempo: baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. This is a six-item scale with 5 response categories [0="Not confident at all" to 4= "Very confident"]. Higher scores reflect higher confidence in decision making.

baseline, 2-week post-test and 3 months
Technology awareness
Lasso di tempo: baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very aware" to 5="Very unaware"] how aware they are about technologies available to support their partner's care and safety.

baseline and 2-week post-test
Technology understanding
Lasso di tempo: baseline and 2-week post-test

4 items assess perceived understanding of each of 4 technologies featured in the intervention [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Perception of PLWD/MCI's technology understanding
Lasso di tempo: baseline and 2-week post-test

4 items assess care partner's perception of how well their study partner understands of each of 4 technologies featured in the intervention [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Satisfaction with dyadic communication about technology
Lasso di tempo: baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very satisfied" to 5="Very dissatisfied"] how satisfied they are with their discussion with their study partner about using technology to support their care or safety.

baseline and 2-week post-test
Intention to honor preferences
Lasso di tempo: baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very likely" to 5="Very unlikely"] how likely they are to honor their partner's preferences for how technology is used in their care.

baseline and 2-week post-test
Dyadic alignment about technology use
Lasso di tempo: baseline and 2-week post-test

Participant is asked how much they agree with their partner about using technologies to support their care [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Had conversation about technology
Lasso di tempo: baseline and 2-week post-test

Participant answers yes, no or unsure if they've ever had a conversation with their study partner about technology to support care or safety.

baseline and 2-week post-test

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Shared technology preferences
Lasso di tempo: baseline, 2-week post-test and 3 months

Participant answer yes or no if they have ever shared the PLWD/MCI's preferences about technologies to support their care with anyone else.

baseline, 2-week post-test and 3 months
Confidence preferences will be honored
Lasso di tempo: baseline, 2-week post-test and 3 months

Participant rates on a 5-point Likert scale [1=Strongly agree to 5=Strongly disagree] about their belief the PLWD/MCI's choices about these technologies will be honored.

baseline, 2-week post-test and 3 months
Satisfaction with involvement of primary participant in technology use decisions
Lasso di tempo: baseline, 2-week post-test and 3 months

Participant rates on a 5-point Likert scale [1="Very satisfied" to 5="Very dissatisfied"] how satisfied they are with how involved the primary participant is in decisions about technology to support their care.

baseline, 2-week post-test and 3 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Clara Berridge, PhD, University of Washington

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

7 febbraio 2025

Completamento primario (Effettivo)

25 agosto 2026

Completamento dello studio (Effettivo)

25 agosto 2026

Date di iscrizione allo studio

Primo inviato

3 gennaio 2025

Primo inviato che soddisfa i criteri di controllo qualità

7 febbraio 2025

Primo Inserito (Effettivo)

10 febbraio 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

25 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 settembre 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi